Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects

AIMS/INTRODUCTION: Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are used for treatment of type 2 diabetes mellitus worldwide. However, some patients do not respond well to the therapy, and caution must be taken for certain patients, including those with reduced insulin secretory capacity. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Takaaki, Fujimoto, Hiroyuki, Fujita, Naotaka, Hamamatsu, Keita, Yabe, Daisuke, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610126/
https://www.ncbi.nlm.nih.gov/pubmed/32323451
http://dx.doi.org/10.1111/jdi.13281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610126/
https://www.ncbi.nlm.nih.gov/pubmed/32323451
http://dx.doi.org/10.1111/jdi.13281

Ejemplares similares